Open AccessModification of the existing maximum residue levels for mandipropamid in various crops
Author(s) -
Abdourahime Himdata,
Anastassiadou Maria,
Brancato Alba,
Brocca Daniela,
Carrasco Cabrera Luis,
De Lentdecker Chloe,
Ferreira Lucien,
Greco Luna,
Jarrah Samira,
Kardassi Dimitra,
Leuschner Renata,
Lostia Alfonso,
Lythgo Christopher,
Medina Paula,
Miron Ileana,
Molnar Tunde,
Nave Stefanie,
Pedersen Ragnor,
Raczyk Marianna,
Reich Hermine,
Ruocco Silvia,
Sacchi Angela,
Santos Miguel,
Stanek Alois,
Sturma Juergen,
Tarazona Jose,
Theobald Anne,
Vagenende Benedicte,
Verani Alessia,
VillamarBouza Laura
Publication year - 2019
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2019.5599
Subject(s) - residue (chemistry) , agriculture , agricultural science , enforcement , risk assessment , crop , business , toxicology , environmental science , agronomy , biology , political science , computer science , law , ecology , biochemistry , computer security
In accordance with Article 6 of Regulation ( EC ) No 396/2005, the applicants Syngenta Crop Protection B.V. and Agriculture and Horticulture Development Board ( AHDB ) submitted, respectively, a request to the competent national authorities in the Netherlands and United Kingdom to modify the existing maximum residue levels ( MRL s) for the active substance mandipropamid in various crops. The data submitted in support of the request were found to be sufficient to derive MRL proposals for beetroots, radishes, cauliflowers, Brussels sprouts, witloofs/Belgian endives, peas (without pods) and globe artichokes. Adequate analytical methods for enforcement are available to control the residues of mandipropamid in plant matrices under consideration at the validated limit of quantification ( LOQ ) of 0.01 mg/kg. Based on the risk assessment results, EFSA concluded that the intake of residues resulting from the use of mandipropamid according to the reported agricultural practices is unlikely to present a risk to consumer health.